These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30807825)

  • 1. Fluid and imaging biomarkers for Huntington's disease.
    Zeun P; Scahill RI; Tabrizi SJ; Wild EJ
    Mol Cell Neurosci; 2019 Jun; 97():67-80. PubMed ID: 30807825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.
    Scahill RI; Zeun P; Osborne-Crowley K; Johnson EB; Gregory S; Parker C; Lowe J; Nair A; O'Callaghan C; Langley C; Papoutsi M; McColgan P; Estevez-Fraga C; Fayer K; Wellington H; Rodrigues FB; Byrne LM; Heselgrave A; Hyare H; Sampaio C; Zetterberg H; Zhang H; Wild EJ; Rees G; Robbins TW; Sahakian BJ; Langbehn D; Tabrizi SJ
    Lancet Neurol; 2020 Jun; 19(6):502-512. PubMed ID: 32470422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biofluid Biomarkers in Huntington's Disease.
    Rodrigues FB; Byrne LM; Wild EJ
    Methods Mol Biol; 2018; 1780():329-396. PubMed ID: 29856027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.
    Byrne LM; Rodrigues FB; Johnson EB; Wijeratne PA; De Vita E; Alexander DC; Palermo G; Czech C; Schobel S; Scahill RI; Heslegrave A; Zetterberg H; Wild EJ
    Sci Transl Med; 2018 Sep; 10(458):. PubMed ID: 30209243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Imaging Biomarkers for Huntington's Disease and Other Hereditary Choreas.
    Fazio P; Paucar M; Svenningsson P; Varrone A
    Curr Neurol Neurosci Rep; 2018 Oct; 18(12):85. PubMed ID: 30291526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huntingtin silencing delays onset and slows progression of Huntington's disease: a biomarker study.
    Liu H; Zhang C; Xu J; Jin J; Cheng L; Miao X; Wu Q; Wei Z; Liu P; Lu H; van Zijl PCM; Ross CA; Hua J; Duan W
    Brain; 2021 Nov; 144(10):3101-3113. PubMed ID: 34043007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Magnetic Resonance Imaging in Huntington's Disease.
    Wilson H; Dervenoulas G; Politis M
    Int Rev Neurobiol; 2018; 142():335-380. PubMed ID: 30409258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Multidimensional Brain Imaging in Huntington's Disease Animal Models.
    Flament J; Hantraye P; Valette J
    Methods Mol Biol; 2018; 1780():285-301. PubMed ID: 29856025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huntington's disease: 4 big questions.
    Nowogrodzki A
    Nature; 2018 May; 557(7707):S48. PubMed ID: 29844555
    [No Abstract]   [Full Text] [Related]  

  • 10. Study protocol of IMAGINE-HD: Imaging iron accumulation and neuroinflammation with 7T-MRI + CSF in Huntington's disease.
    van de Zande NA; Bulk M; Najac C; van der Weerd L; de Bresser J; Lewerenz J; Ronen I; de Bot ST
    Neuroimage Clin; 2023; 39():103450. PubMed ID: 37327706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between sex and neurofilament light chain on brain structure and clinical severity in Huntington's disease.
    Sampedro F; Martinez-Horta S; Pérez-Pérez J; Perez-Gonzalez R; Horta-Barba A; Campolongo A; Aracil-Bolaños I; Gomez-Anson B; Kulisevsky J
    Ann Clin Transl Neurol; 2021 Dec; 8(12):2309-2313. PubMed ID: 34761569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients.
    Wild EJ; Boggio R; Langbehn D; Robertson N; Haider S; Miller JR; Zetterberg H; Leavitt BR; Kuhn R; Tabrizi SJ; Macdonald D; Weiss A
    J Clin Invest; 2015 May; 125(5):1979-86. PubMed ID: 25844897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?
    Niemelä V; Landtblom AM; Blennow K; Sundblom J
    PLoS One; 2017; 12(2):e0172762. PubMed ID: 28241046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
    Byrne LM; Rodrigues FB; Blennow K; Durr A; Leavitt BR; Roos RAC; Scahill RI; Tabrizi SJ; Zetterberg H; Langbehn D; Wild EJ
    Lancet Neurol; 2017 Aug; 16(8):601-609. PubMed ID: 28601473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of biomarkers for Huntington's disease.
    Weir DW; Sturrock A; Leavitt BR
    Lancet Neurol; 2011 Jun; 10(6):573-90. PubMed ID: 21601164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of Ultrasensitive Mutant Huntingtin Detection in Human Cerebrospinal Fluid by Single Molecule Counting Immunoassay.
    Fodale V; Boggio R; Daldin M; Cariulo C; Spiezia MC; Byrne LM; Leavitt BR; Wild EJ; Macdonald D; Weiss A; Bresciani A
    J Huntingtons Dis; 2017; 6(4):349-361. PubMed ID: 29125493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington's disease.
    Lowe AJ; Sjödin S; Rodrigues FB; Byrne LM; Blennow K; Tortelli R; Zetterberg H; Wild EJ
    PLoS One; 2020; 15(8):e0233820. PubMed ID: 32804976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Imaging of Huntington's Disease.
    Ciarmiello A; Giovacchini G; Giovannini E; Lazzeri P; Borsò E; Mannironi A; Mansi L
    J Cell Physiol; 2017 Aug; 232(8):1988-1993. PubMed ID: 27791273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease.
    Caron NS; Banos R; Yanick C; Aly AE; Byrne LM; Smith ED; Xie Y; Smith SEP; Potluri N; Findlay Black H; Casal L; Ko S; Cheung D; Kim H; Seong IS; Wild EJ; Song JJ; Hayden MR; Southwell AL
    J Neurosci; 2021 Jan; 41(4):780-796. PubMed ID: 33310753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.